Sitemap > Breaking Research > Cardiovascular Disorders
Displaying 1351 - 1400 of 4862 results
- Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
- Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase.
- Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells.
- Haem oxygenase-1 genotype and cardiovascular adverse events in patients with peripheral artery disease.
- 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
- TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice.
- Mutation in sodium-calcium exchanger 1 (NCX1) causes cardiac fibrillation in zebrafish.
- Increase in heme oxygenase-1 levels ameliorates renovascular hypertension.
- Early detection of progressive renal dysfunction in patients with coronary artery disease.
- Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population.
- Benefits associated with an early hemoglobin response to epoetin alfa therapy in the treatment of chemotherapy-related anemia.
- Serotonin induces pulmonary artery smooth muscle cell migration.
- Pharmacological characterization of the active synthetic factor Xa inhibitors M55551 and M55165.
- Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
- Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
- Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability.
- The activity of pathway-selective estrogen receptor ligands in experimental septic shock.
- Macrophage migration inhibitory factor within the alveolar spaces induces changes in the heart during late experimental sepsis.
- The effect of systemic leptin administration on aorta smooth muscle responses in diabetic rats.
- Progress and prospects: cell based regenerative therapy for cardiovascular disease.
- Prevalence of antiplatelet therapy in patients with diabetes.
- Autocrine role of vascular IL-15 in intimal thickening.
- Adiponectin and inflammatory markers in peripheral arterial occlusive disease.
- Antiarrhythmic activity of 4,6-di(het)aryl-5-nitro-3,4-dihydropyrimidin-(1H)-2-ones and its effects on arterial pressure in rats.
- Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy.
- Cellular pathology of atherosclerosis: smooth muscle cells promote adhesion of platelets to cocultured endothelial cells.
- Calpain inhibition reduces infarct size and improves global hemodynamics and left ventricular contractility in a porcine myocardial ischemia/reperfusion model.
- Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats.
- Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse.
- COX-2 mediates morphine-induced delayed cardioprotection via an iNOS-dependent mechanism.
- Carotid atherosclerotic plaque instability in patients with acute myocardial infarction.
- Mitochondrial dysfunction associated with cardiac ischemia/reperfusion can be attenuated by oxygen tension control. Role of oxygen-free radicals and cardiolipin.
- Kyotorphin has a novel action on rat cardiac muscle.
- Efficacy of peroxisome proliferative activated receptor (PPAR)-alpha ligands, fenofibrate, on intimal hyperplasia and constrictive remodeling after coronary angioplasty in porcine models.
- The design and synthesis of YC-1 analogues as probes for soluble guanylate cyclase.
- Beneficial effects of add-on hydrochlorothiazide in rats with myocardial infarction optimally treated with quinapril.
- Incident atrial fibrillation and mortality in older adults with heart failure.
- Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice.
- A crucial role of mitochondrial Hsp40 in preventing dilated cardiomyopathy.
- The control of dyslipidemia in outpatient clinics in Greece (OLYMPIC) Study.
- Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury--Evidence for a role of K ATP channels.
- Human genetic evidence that OX40 is implicated in myocardial infarction.
- Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium.
- Differential regulation of Kir4.1 and Kir2.1 expression in the ischemic rat retina.
- Inhibition of phosphodiesterase 5 selectively reverses nitrate tolerance in the venous circulation.
- The G protein-gated potassium current I(K,ACh) is constitutively active in patients with chronic atrial fibrillation.
- Cross-sectional relations of peripheral microvascular function, cardiovascular disease risk factors, and aortic stiffness: the Framingham Heart Study.
- Protease nexin-2/amyloid beta-protein precursor limits cerebral thrombosis.
- Role of angiotensin II in the evolution of diastolic heart failure.
- Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 Next >